Glaukos Operating Income 2014-2025 | GKOS

Glaukos annual/quarterly operating income history and growth rate from 2014 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Glaukos operating income for the quarter ending March 31, 2025 was $-0.021B, a 47.07% decline year-over-year.
  • Glaukos operating income for the twelve months ending March 31, 2025 was $-0.104B, a 22.85% decline year-over-year.
  • Glaukos annual operating income for 2024 was $-0.122B, a 4.92% decline from 2023.
  • Glaukos annual operating income for 2023 was $-0.129B, a 56.35% increase from 2022.
  • Glaukos annual operating income for 2022 was $-0.082B, a 150.4% increase from 2021.
Glaukos Annual Operating Income
(Millions of US $)
2024 $-122
2023 $-129
2022 $-82
2021 $-33
2020 $-124
2019 $-50
2018 $-13
2017 $-2
2016 $4
2015 $-10
2014 $-13
2013 $-14
Glaukos Quarterly Operating Income
(Millions of US $)
2025-03-31 $-21
2024-12-31 $-29
2024-09-30 $-25
2024-06-30 $-30
2024-03-31 $-39
2023-12-31 $-39
2023-09-30 $-28
2023-06-30 $-29
2023-03-31 $-33
2022-12-31 $-34
2022-09-30 $-22
2022-06-30 $-37
2022-03-31 $10
2021-12-31 $-18
2021-09-30 $11
2021-06-30 $-14
2021-03-31 $-12
2020-12-31 $-11
2020-09-30 $-12
2020-06-30 $-47
2020-03-31 $-53
2019-12-31 $-30
2019-09-30 $-12
2019-06-30 $-6
2019-03-31 $-2
2018-12-31 $2
2018-09-30 $-7
2018-06-30 $-4
2018-03-31 $-4
2017-12-31 $1
2017-09-30 $1
2017-06-30 $-4
2017-03-31 $0
2016-12-31 $0
2016-09-30 $1
2016-06-30 $2
2016-03-31 $1
2015-12-31 $-2
2015-09-30 $-2
2015-06-30 $-5
2015-03-31 $-1
2014-12-31 $-5
2014-09-30 $-2
2014-06-30 $-2
2014-03-31 $-4
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $5.487B $0.383B
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $193.381B 84.70
Thermo Fisher Scientific (TMO) United States $148.604B 17.98
Edwards Lifesciences (EW) United States $43.989B 28.84
Alcon (ALC) Switzerland $42.676B 28.84
IDEXX Laboratories (IDXX) United States $40.337B 46.36
DexCom (DXCM) United States $33.137B 51.22
STERIS (STE) Ireland $23.875B 26.33
IQVIA Holdings (IQV) United States $23.701B 13.27
Mettler-Toledo (MTD) United States $23.155B 27.54
Waters (WAT) United States $20.612B 29.08
SONOVA HOLDING (SONVY) Switzerland $19.146B 0.00
Hologic (HOLX) United States $12.096B 13.14
Sysmex ADR (SSMXY) Japan $10.632B 30.16
Penumbra (PEN) United States $10.399B 81.62
Masimo (MASI) United States $8.140B 30.03
Globus Medical (GMED) United States $7.982B 19.02
Teleflex (TFX) United States $5.337B 8.81
TransMedics (TMDX) United States $4.203B 91.36
Integer Holdings (ITGR) United States $4.128B 21.63
PROCEPT BioRobotics (PRCT) United States $3.175B 0.00
LivaNova (LIVN) United Kingdom $2.284B 13.60
Veracyte (VCYT) United States $2.127B 29.85
Nihon Kohden (NHNKY) Japan $1.943B 22.28
Elekta AB (EKTAY) Sweden $1.922B 17.28
Alphatec Holdings (ATEC) United States $1.820B 0.00
Tandem Diabetes Care (TNDM) United States $1.380B 0.00
Artivion (AORT) United States $1.222B 114.44
Pulse Biosciences (PLSE) United States $1.136B 0.00
OPKO Health (OPK) United States $0.999B 0.00
Integra LifeSciences Holdings (IART) United States $0.956B 5.08
SiBone (SIBN) United States $0.783B 0.00
IRadimed (IRMD) United States $0.650B 32.96
RxSight (RXST) United States $0.637B 0.00
Beta Bionics (BBNX) United States $0.626B 0.00
Mesa Laboratories (MLAB) United States $0.597B 13.05
NeuroPace (NPCE) United States $0.580B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.569B 8.86
Delcath Systems (DCTH) United States $0.561B 0.00
OrthoPediatrics (KIDS) United States $0.506B 0.00
AxoGen (AXGN) United States $0.504B 0.00
Semler Scientific (SMLR) United States $0.494B 13.15
ORTHOFIX MEDICAL INC (OFIX) United States $0.435B 0.00
AngioDynamics (ANGO) United States $0.384B 0.00
Treace Medical Concepts (TMCI) United States $0.370B 0.00
ClearPoint Neuro (CLPT) United States $0.333B 0.00
Pacific Biosciences Of California (PACB) United States $0.277B 0.00
Neuronetics (STIM) United States $0.263B 0.00
Tactile Systems Technology (TCMD) United States $0.219B 13.27
Alpha Tau Medical (DRTS) Israel $0.211B 0.00
Inogen (INGN) United States $0.176B 0.00
Spectral Diagnostics (EDTXF) Canada $0.175B 0.00
CVRx (CVRX) United States $0.174B 0.00
908 Devices (MASS) United States $0.172B 0.00
Lucid Diagnostics (LUCD) United States $0.172B 0.00
Sight Sciences (SGHT) United States $0.165B 0.00
Accuray (ARAY) United States $0.162B 0.00
LENSAR (LNSR) United States $0.160B 0.00
Biosig Technologies (BSGM) United States $0.144B 0.00
Rapid Micro Biosystems (RPID) United States $0.143B 0.00
Anteris Technologies Global (AVR) Australia $0.131B 0.00
Atossa Genetics (ATOS) United States $0.107B 0.00
Microbot Medical (MBOT) United States $0.097B 0.00
Monogram Orthopaedics (MGRM) United States $0.093B 0.00
InspireMD (NSPR) Israel $0.078B 0.00
Sensus Healthcare (SRTS) United States $0.077B 46.90
EDAP TMS S.A (EDAP) France $0.066B 0.00
EnVVeno Medical (NVNO) United States $0.059B 0.00
Covalon Technologies (CVALF) Canada $0.055B 16.67
Hyperfine (HYPR) United States $0.042B 0.00
Vicarious Surgical (RBOT) United States $0.040B 0.00
Spectral AI (MDAI) United States $0.037B 0.00
Envoy Medical (COCH) United States $0.035B 0.00
Precision Optics (POCI) United States $0.033B 0.00
Baird Medical Investment Holdings (BDMD) $0.032B 0.00
DarioHealth (DRIO) United States $0.032B 0.00
Adagio Medical Holdings (ADGM) United States $0.018B 0.00
NexGel (NXGL) United States $0.017B 0.00
PAVmed (PAVM) United States $0.011B 0.00
WORK Medical Technology Group (WOK) China $0.010B 0.00
Ekso Bionics Holdings (EKSO) United States $0.010B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.006B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.001B 0.00
Accelerate Diagnostics (AXDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.58
Spinal Elements Holdings (SPEL) United States $0.000B 0.00